The EUTOS long‐term survival score predicts disease‐specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice‐based cohort

The European Treatment and Outcome Study (EUTOS) long‐term survival (ELTS) score predicts disease‐specific death in patients with chronic myeloid leukemia (CML) being treated with imatinib during the chronic phase (CP) of the disease. However, it is unclear whether the ELTS score predicts CML‐relate...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Eriko, Iriyama, Noriyoshi, Tokuhira, Michihide, Takaku, Tomoiku, Ishikawa, Maho, Nakazato, Tomonori, Sugimoto, Kei‐Ji, Fujita, Hiroyuki, Kimura, Yuta, Fujioka, Isao, Asou, Norio, Komatsu, Norio, Kizaki, Masahiro, Hatta, Yoshihiro, Kawaguchi, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724301/
https://www.ncbi.nlm.nih.gov/pubmed/33037866
http://dx.doi.org/10.1002/cam4.3516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724301/
https://www.ncbi.nlm.nih.gov/pubmed/33037866
http://dx.doi.org/10.1002/cam4.3516

Ejemplares similares